How Japan Regulates Cosmetic Ingredients With Positive Lists

A formulator once told me she assumed that if an ingredient wasn't banned anywhere, it was probably fine everywhere. Japan is the market that breaks that assumption fastest, because its system doesn't just ask what's forbidden. In places, it asks what's specifically permitted, and if your ingredient isn't on that list, the default answer isn't yes.

The structural difference from a restricted-list system

Most of the markets a North American formulator deals with day to day, Canada's Hotlist being the clearest example, work on a restricted and prohibited list model. The default assumption is that an ingredient is usable unless it's specifically named as banned or capped at a certain concentration. You check your formula against the list, and if nothing matches, you're generally clear.

Japan's framework layers in positive lists for certain ingredient categories, meaning specific substances are named as the ones allowed for that use, and anything not on the list isn't automatically permitted just because it's absent from a prohibited list. That's a meaningfully different way of thinking about compliance. A restricted-list market asks "is this banned." A positive-list category asks "is this specifically approved," which flips the burden of proof.

This shows up most clearly around UV filters and certain colourants, where Japan maintains lists of specifically approved substances for those functions, rather than treating them as generally permitted subject to exclusions.

Why this catches formulators off guard

Say you've built a sunscreen-adjacent moisturizer, or a tinted product using a colourant that's well established and compliant across Canada, the US, and the EU. None of that guarantees the same colourant appears on Japan's approved list for that use category. The ingredient isn't "banned" in any conventional sense you'd find by searching a prohibited substances list. It's simply not on the specific list of things approved for that function in that market, and the practical effect is the same: you can't use it there for that purpose without finding an alternative or pursuing a different regulatory pathway.

This is also where the line between cosmetics and quasi-drugs matters in Japan specifically. Certain product claims and ingredient combinations that would sit comfortably in "cosmetic" territory elsewhere get pulled into a quasi-drug category in Japan, which carries its own separate framework and approval expectations, closer in spirit to how many markets treat drugs versus cosmetics for things like anti-acne or antiperspirant claims.

What this means for a formula built for other markets first

If you've formulated primarily with Canada or the US in mind and you're now eyeing Japan as a market, don't assume the ingredient list transfers over cleanly just because it passed Hotlist screening and an FDA listing. The practical steps:

1. Identify any UV filters, certain colourants, or preservatives in your formula that might fall under a positive-list category in Japan
2. Check whether each of those specific ingredients appears on the applicable approved list for that function, rather than checking a general prohibited list
3. Watch for claims that might push the product into quasi-drug territory under Japan's framework, since that changes the entire regulatory pathway
4. Budget real time for this, since reformulating around a positive-list gap, if you hit one, usually means sourcing a genuinely different active or colourant, not just adjusting a concentration

A comparison to keep in your head

	Canada (Hotlist model)	Japan (positive-list categories)
Default assumption	Permitted unless listed as prohibited/restricted	Not automatically permitted for certain categories unless specifically listed
Where this applies	Broadly, across most ingredient types	Particularly UV filters, certain colourants
Practical check	Screen against prohibited/restricted list	Confirm specific ingredient appears on the approved list for that function
Product category complication	True soap vs. cosmetic claims	Cosmetic vs. quasi-drug classification

The honest takeaway

Regulatory specifics shift, and Japan's exact lists and category boundaries are the kind of detail that genuinely changes over time, so treat this as a framework for how to think about the market rather than a substitute for checking the current source before you commit to a formula for that market. The core lesson holds regardless of the specific list contents on any given day: don't assume "not banned elsewhere" means "approved here."

Cosmetic Comply is built around Canada today, with the US, EU, and Australia on the way, so if Japan is on your roadmap, treat it as its own research project for now rather than expecting a shortcut, and lean on a formula-specific check with the current Japanese regulatory source before you commit packaging and marketing spend to that market.